Neutrogena Lost Dermatologists and Missed Out on the $42 Billion Beauty Boom [Yahoo! Finance]
Kenvue Inc. (KVUE)
Company Research
Source: Yahoo! Finance
The family had shelves stocked with Neutrogena products. But the 20-year-old wanted the brand she saw on TikTok, said the employee who has since left the company. Most Read from Bloomberg Americans Are Racking Up ‘Phantom Debt' That Wall Street Can't Track Trump Judge Indefinitely Postpones Documents Case Trial One Out of Every 24 New York City Residents Is Now a Millionaire US Pauses Arms Shipment to Israel on Rafah Invasion Concerns Kenvue Inc., which owns Neutrogena and Aveeno, has seen its skin-care market share plummet to less than 14% in 2023 from 23% in 2019 — when it was the biggest in the US, according to retail data from researcher Circana. Neutrogena is missing out on what is now a $42 billion US beauty market because it retreated precisely when rivals went all in. What had once been a nimble, innovative company, became slow-moving and cautious, according to four former employees who weren't authorized to speak publicly on the matter. Faced with pandemic-ind
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Kenvue Releases Inaugural Healthy Lives Mission Report [Yahoo! Finance]Yahoo! Finance
- Kenvue Releases Inaugural Healthy Lives Mission ReportBusiness Wire
- Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 42% Above Its Share Price [Yahoo! Finance]Yahoo! Finance
- J&J Acquires Experimental Eczema Drug in $1.25 Billion Cash Deal [BNN Bloomberg (Canada)]BNN Bloomberg
- Kenvue Inc. (NYSE: KVUE) had its "neutral" rating re-affirmed by analysts at Citigroup Inc.. They now have a $21.00 price target on the stock.MarketBeat
KVUE
Earnings
- 5/7/24 - Beat
KVUE
Sec Filings
- 6/5/24 - Form 4
- 5/28/24 - Form 4
- 5/28/24 - Form 4
- KVUE's page on the SEC website